Mason RP, Jacob R, Corbalan JJ, Malinski T. Eicosapentaenoic acid reduces small dense low density lipoprotein oxidation and improves endothelial function in vitro as compared to other triglyceride-lowering agents [abstract]. J Am Coll Cardiol. 2015;65:A2139.
Bays HE, Ballantyne CM, Braeckman RA, Stirtan WG, Doyle RT Jr, Philip S, Soni PN, Juliano RA. Icosapent ethyl (eicosapentaenoic acid ethyl ester): effects upon high-sensitivity C-reactive protein and lipid parameters in patients with metabolic syndrome. Metab Syndr Relat Disord. 2015 Apr 20 [Epub ahead of print].
Free:
http://online.liebertpub.com/doi/pdfplus/10.1089/met.2014.0137
Mason RP, Jacob RF. Eicosapentaenoic acid (EPA) reduces glucose-induced small dense low-density lipoprotein oxidation in vitro in a manner distinct from other triglyceride-lowering agents and vitamin E [abstract 705-P]. Diabetes. 2015;64(suppl 1):A178-A179. Posting of the abstract is pending permission by the Journal Diabetes.
Mason RP, Jacob RF. Eicosapentaenoic acid (EPA), but not other TG-lowering agents, reduces cholesterol domain levels in atherosclerotic-like model membranes [abstract 176]. J Clin Lipidol. 2015;9:466.
Ballantyne CM, Bays HE, Braeckman RA, et al. Icosapent ethyl (eicosapentaenoic acid ethyl ester): effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies [abstract 172]. J Clin Lipidol. 2015;9:463-4.
Ballantyne CM, Bays HE, Braeckman RA, et al. Icosapent ethyl (eicosapentaenoic acid ethyl ester): effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies [abstract 172]. J Clin Lipidol. 2015;9:463-4.
Stirtan WG, Braeckman RA, Bays HE, Ballantyne CM, Soni PN, Juliano RA. Pharmacokinetic and triglyceride-lowering pharmacodynamic effects of icosapent ethyl (eicosapentaenoic acid ethyl ester) across clinical studies [abstract 173]. J Clin Lipidol. 2015;9:464.
Stirtan WG, Braeckman RA, Bays HE, Ballantyne CM, Soni PN, Juliano RA. Pharmacokinetic and triglyceride-lowering pharmacodynamic effects of icosapent ethyl (eicosapentaenoic acid ethyl ester) across clinical studies [abstract 173]. J Clin Lipidol. 2015;9:464.
